Filter Search


Europe


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Doxylamine 6.96 Mg / Pyridoxine 8.23 ??mg Hvw (cariban) 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ibuprofen 200 Mg In The Dosage Form Fta 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Benazepril + Hct (fta) 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Midazolam Amp, Ilo, Iil Not In The Standard Size N3 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pamidronic Acid. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Cetirizine In The Dosage Forms Tro And Tei. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bezafibrate In The Dosage Form Fta. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130a Paragraph 8 Sgb V With The Active Ingredient Mycophenolic Acid In The Dosage Form Pse. 2026-11-10
Bulgaria Delivery Of Medical Devices For Umbal "st. Ivan Rilski" Ead 2026-11-10
Germany Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Adalimumab 2026-11-10
Whats app